← Back to Search

Habit Reversal Training for Tourette Syndrome

N/A
Waitlist Available
Led By Joseph F McGuire, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 week after completion of hrt
Awards & highlights

Summary

This trial tests how well children with Tourette syndrome can learn and remember to stop their tics using a special task. It aims to understand and improve behavioral treatments for controlling tics.

Eligible Conditions
  • Tourette Syndrome
  • Habit Reversal Training
  • Tics

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 week after completion of hrt
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 week after completion of hrt for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tic severity as assessed by the Hopkins Motor and Vocal Tic Scale (HM/VTS)
Secondary study objectives
Tic severity as assessed by the Yale Global Tic Severity Scale-Revised (YGTSS)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Habit Reversal TrainingExperimental Treatment1 Intervention
Habit Reversal Training (HRT) is a multi-component evidence-based treatment for tics. It will be delivered over 4 two-hour sessions in an intensive format.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Habit Reversal Training
2020
N/A
~80

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,307 Previous Clinical Trials
14,861,889 Total Patients Enrolled
8 Trials studying Tourette Syndrome
289 Patients Enrolled for Tourette Syndrome
Joseph F McGuire, PhDPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
160 Total Patients Enrolled
2 Trials studying Tourette Syndrome
160 Patients Enrolled for Tourette Syndrome
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top